An approach to validating criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritis (Q35053510)

6 August 2017

title

An approach to validating criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritis (English)

1 reference

systemic lupus erythematosus

6 August 2017

1 reference

1 reference

5

Brad H Rovin

1 reference

6 August 2017

Stacy Ardoin

1

1 reference

6 August 2017

Daniel J Birmingham

2

1 reference

6 August 2017

Paul L Hebert

3

1 reference

6 August 2017

Chack-Yung Yu

4

1 reference

6 August 2017

Lee A Hebert

6

1 reference

6 August 2017

publication date

1 July 2011

1 reference

6 August 2017

published in

Arthritis & Rheumatology

1 reference

6 August 2017

volume

63

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

2031-2037

1 reference

Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117977

Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117977

D-dimer level and the risk for thrombosis in systemic lupus erythematosus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117977

Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117977

Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European A

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117977

Management of glomerular proteinuria: a commentary

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117977

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117977

"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117977

Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis

8 July 2018

1 reference

Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus

21 January 2018

1 reference

Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare.

21 January 2018

1 reference

Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele.

21 January 2018

1 reference

Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis

21 January 2018

1 reference

Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis

21 January 2018

1 reference

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Outcome criteria for lupus nephritis trials: a critical overview

21 January 2018

1 reference

12 December 2020

Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy

1 reference

12 December 2020

Timed urine collections are not needed to measure urine protein excretion in clinical practice

1 reference

12 December 2020

The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials

1 reference

12 December 2020

Revised British Isles Lupus Assessment Group 2004 index: A reliable tool for assessment of systemic lupus erythematosus activity

1 reference

12 December 2020

Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares.

1 reference

12 December 2020

Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patients

1 reference

12 December 2020

Oral cyclophosphamide is on the verge of extinction as therapy for severe autoimmune diseases (especially lupus): should nephrologists care?

1 reference

12 December 2020

Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer

1 reference

12 December 2020

Urine chemokines as biomarkers of human systemic lupus erythematosus activity

1 reference

12 December 2020

Identifiers

DOI

10.1002/ART.30345

1 reference

6 August 2017

1 reference

6 August 2017

1 reference